Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1352 of 6351
-
Can diabetes disrupt the Brain-Heart link?
Knowledge-focused Recruiting nowType 2 Diabetes Mellitus (T2DM) is associated with chronic hyperglycemia and metabolic disturbances that affect not only glucose metabolism but also the central nervous system, autonomic nervous system, and cardiovascular function. Growing evidence suggests that individuals with …
Sponsor: Hacettepe University • Aim: Knowledge-focused
Last updated Aug 13, 2026 00:00 UTC
-
Could a common liver drug replace steroids for immunotherapy side effects?
Disease control Recruiting nowThe clinical trial aims to compare the effectiveness of ursodeoxycholic acid (UDCA) to corticosteroids in treating cholestatic hepatitis induced by immune checkpoint inhibitors (ICIs) over a 21-day period. The trial presents a detailed scientific justification for comparing UDCA…
Phase 2 • Sponsor: University Hospital, Montpellier • Aim: Disease control
Last updated Sep 10, 2026 09:00 UTC
-
Pregnant women with hepatitis c get new hope in drug trial
Disease control Recruiting nowThis is a Phase I/II, multi-site, open-label, single arm study to describe the pharmacokinetics (PK) and safety of glecaprevir/pibrentasvir (GLE/PIB) initiated during pregnancy in women with hepatitis C virus (HCV) infection (acute or chronic) with or without HIV and to evaluate …
Phase 1/2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
Can immune markers predict breast cancer treatment success?
Knowledge-focused Recruiting nowThe goal of this clinical trial is to identify cellular and molecular determinants of response to neoadjuvant immunochemotherapy in women aged 18 or older with early-stage triple-negative breast cancer (TNBC). The main questions it aims to answer are: * Can detailed immune profi…
Sponsor: Center Eugene Marquis • Aim: Knowledge-focused
Last updated Jul 12, 2026 00:00 UTC
-
Texts after trauma: new study tests simple tools to prevent PTSD and opioid abuse
Symptom relief By invitation onlyThe goal of this clinical trial is to learn whether a video given for recent sexual assault survivors and/or a 3-week text messaging intervention with similar content is effective at reducing mental health problems and substance misuse following the assault.
Sponsor: University of Wisconsin, Madison • Aim: Symptom relief
Last updated Jul 09, 2026 00:00 UTC
-
New pill could ease osteoarthritis knee pain without surgery
Symptom relief Recruiting nowThe main purpose of this study is to test the safety and efficacy of study drug for the treatment of knee pain due to osteoarthritis (OA). This trial is part of the chronic pain master protocol H0P-MC-CPMP (NCT05986292), which is a protocol to accelerate the development of new tr…
Phase 2 • Sponsor: Eli Lilly and Company • Aim: Symptom relief
Last updated Sep 06, 2026 00:00 UTC
-
New Ultra-Long-Acting HIV shots could mean fewer doses for patients
Disease control Recruiting nowThis study compares the efficacy, safety and tolerability of CAB ULA and RPV ULA administered with CAB long acting (LA) and RPV LA administered in adults and adolescents with HIV who are virologically suppressed on anti-retroviral therapy (ART).
Phase 3 • Sponsor: ViiV Healthcare • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
New asthma shot could help kids breathe easier
Disease control Recruiting nowThis study is aimed at assessing depemokimab as an add-on medicine for the treatment of asthma with type-2 inflammation in participants of 6 to 11 years of age. This study will test how the body processes depemokimab, how the drug works in the body, and its safety and tolerabilit…
Phase 3 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
New anesthetic may protect frail elderly from dangerous blood pressure drops during surgery
Disease control Not yet recruitingPost-induction hypotension (PIH) is a common and critical complication during general anesthesia, particularly in frail elderly patients whose physiological reserves are significantly diminished. PIH is strongly associated with adverse postoperative outcomes, including acute kidn…
Sponsor: General Hospital of Ningxia Medical University • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New DNA vaccine aims to clear Cancer-Causing HPV
Disease control Recruiting nowThis research is being done to test the safety and feasibility of an investigational DNA vaccine called pBI-11 and to find out what effects, if any, it has on women with persistent human papillomavirus 16 (HPV16+) and/or human papillomavirus (HPV18+) cervical infection. The DNA …
Phase 2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Virtual peer mentoring aims to boost cervical cancer screening in ethiopian HIV clinics
Knowledge-focused By invitation onlyProject TICHILALECH ("she can" in Amharic), a five-year, implementation science study, is focused on improving cervical cancer screening, triage, and treatment and integration with human immunodeficiency virus (HIV) care at five Ethiopian hospitals, with a focus on human papillom…
Sponsor: Albert Einstein College of Medicine • Aim: Knowledge-focused
Last updated Jul 03, 2026 00:00 UTC
-
New cocktail of charcoal and laxative could speed up poison recovery
Disease control Recruiting nowGastrointestinal absorption of high dose medication (toxicant) ingested under solid form for suicidal purposes, is prolonged in patients who need intensive care admission and mechanical ventilation. This is due to the large ingested amounts, slowed blood circulation in the digest…
Phase 2 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
New hope for rare amyloidosis: targeted drug combo enters trial
Disease control Recruiting nowThe study aims to evaluate the efficacy and safety of belantamab mafodotin in combination with cyclophosphamide, bortezomib, and dexamethasone in adult participants with newly diagnosed (ND) AL amyloidosis .
Phase 2 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
Experimental pill SHY-ONC6 takes on Hard-to-Treat cancers
Disease control Recruiting nowThis is a Phase 1, first-in-human (FIH), open-label, multicenter study designed to evaluate the safety, tolerability, PK, and preliminary anti-tumor activity of SHY-ONC6 in participants with advanced or metastatic solid tumors who have progressed on or are intolerant to standard …
Phase 1 • Sponsor: SHY Therapeutics • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
AI-Powered app aims to predict Alzheimer's years before symptoms worsen
Knowledge-focused Recruiting nowPopulation ageing is one of the main factors responsible for the global increase in the prevalence of dementia. Recent evidence suggests that modifiable risk factors, such as cardiovascular disease and lifestyle, may increase the risk of developing dementia and contribute to its …
Sponsor: IRCCS Centro San Giovanni di Dio Fatebenefratelli • Aim: Knowledge-focused
Last updated Jul 30, 2026 00:00 UTC
-
Real-World study tracks Ravulizumab's impact on rare kidney disease
Disease control Recruiting nowThis multicenter, observational cohort study uses retrospective collection of past medical history and prospective follow-up to capture longitudinal data on the management and clinical outcomes of patients with atypical hemolytic uremic syndrome (aHUS) treated with ravulizumab as…
Sponsor: AstraZeneca • Aim: Disease control
Last updated Aug 20, 2026 00:00 UTC
-
Smartwatch-Like device could help test DMD drugs in toddlers
Knowledge-focused Recruiting nowEvery year, 100 boys are born in the UK with a rare muscle disease called Duchenne muscular dystrophy. These boys cannot make an important muscle protein called dystrophin. They become weaker as they get older and lose the ability to walk as teenagers. This is a life-limiting con…
Sponsor: University of Oxford • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:06 UTC
-
Can rowing reshape the body and mind?
Knowledge-focused Recruiting nowThis study aims to compare the effects of long-term rowing training on aerobic capacity, physical fitness, heart rate variability, and psychological performance in novice rowers, professional rowers, and healthy controls. Approximately 60 adults aged 18-65 years will be enrolled …
Sponsor: Hacettepe University • Aim: Knowledge-focused
Last updated Aug 09, 2026 00:00 UTC
-
Could video games boost brain and body function in Alzheimer's?
Symptom relief Not yet recruitingAlzheimer's disease (AD) is a progressive neurodegenerative disorder and the most common cause of dementia that accounting for 60% to 80% of all cases (Better, et al., 2023). According to world health organization (WHO), more than 55 million people globally live with dementia, an…
Sponsor: Ziauddin University • Aim: Symptom relief
Last updated Jul 01, 2026 00:00 UTC
-
Hidden vein clot cleanup may prevent chronic leg pain
Disease control Recruiting nowPatients with iliofemoral vein thrombosis are prone to developing post-thrombotic syndrome (PTS). The profunda femoris vein (PFV) is an important inflow of the iliofemoral vein. Profunda femoris vein thrombosis clearance (PFV-TC) may improve the patency of iliofemoral vein and re…
Sponsor: RenJi Hospital • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC